Atropine Sulfate Injection, Solution
Product Images NDC 63323-580

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 63323-580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Atropine Structure)

FDA Label Image

Logo (Fk Logo)

FDA Label Image

Tray (Tray)

This is a medication with the NDC code 63323-580-20. It is Atropine Sulfate Injection, which is used intravenously, intramuscularly, subcutaneously, intraosseously, or endotracheally. It is available in 8mg per 20 mL with a concentration of 0.4 mg per mL. The medication is sold in 10x20mL multiple dose vials and requires a prescription.*

FDA Label Image

Vial (Vial)

This is a description of Atropine Sulfate Injection, USP, which comes in a 20mL vial with a concentration of 0.4mg/mL (8mg/20mL). It can be administered intravenously, intramuscularly, subcutaneously, intraosseously, or via endotracheal use. The vial is intended for multiple doses and requires a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.